CDC Division of Global HIV & TB country profile : Co\u302te d\u2019Ivoire

The U.S. Centers for Disease Control and Prevention (CDC) began its partnership with Co\u302te d\u2019Ivoire in 1987 by opening the Project Retrovirus Co\u302te d'Ivoire (Retro-CI) laboratory in collaboration with the Ivoirian health ministry. In 2004, this partnership expanded when the U.S. President\u2019s Emergency Plan for AIDS Relief (PEPFAR) began providing services in Co\u302te d'Ivoire.CDC supports Co\u302te d\u2019Ivoire in reaching HIV epidemic control. The country has made significant progress by providing testing and treatment to those who have HIV. The 2018 Population based HIV Impact Assessment (PHIA) indicates 88% are on antiretroviral treatment (ART) and almost 80% of those are virally suppressed. Despite these achievements, substantial treatment gaps remain across all sexes and ages, and patient retention remains low. The 2019 priority is to implement approaches for testing, and focus on improving linkage and retention of diagnosed persons living with HIV (PLHIV). CDC will continue to scale-up access to viral load testing to monitor treatment efficacy. CDC will also scale-up tuberculosis (TB) preventive treatment (TPT) to reduce morbidity and mortality among HIV-infected people on ART.Cote-dIvoire.pdf2019665